These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6814785)

  • 1. Arterial-venous nitroglycerin gradient during intravenous infusion in man.
    Armstrong PW; Moffat JA; Marks GS
    Circulation; 1982 Dec; 66(6):1273-6. PubMed ID: 6814785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Watts DG; Moffat JA
    Br J Clin Pharmacol; 1983 Oct; 16(4):385-90. PubMed ID: 6414501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized delivery systems for intravenous nitroglycerin. Are they necessary?
    Young JB; Pratt CM; Farmer JA; Luck JC; Fennell WH; Roberts R
    Am J Med; 1984 Jun; 76(6A):27-37. PubMed ID: 6430075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.
    Makhoul N; Dakak N; Flugelman MY; Merdler A; Shefer A; Schneeweiss A; Halon DA; Lewis BS
    Am J Cardiol; 1990 Jun; 65(21):28J-31J. PubMed ID: 2112336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
    Tsutamoto T; Kinoshita M; Ohbayashi Y; Wada A; Maeda Y; Adachi T
    Circulation; 1994 Aug; 90(2):823-9. PubMed ID: 8044954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
    Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
    Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
    Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
    Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP).
    Peng LM; Chen XP; Sun J; Guo YJ; Li L; Mo L; Xie W; Li YJ; Yang TL; Li CC
    Int J Clin Pharmacol Ther; 2012 Oct; 50(10):701-11. PubMed ID: 22909898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of nitric oxide in exhaled air during administration of nitroglycerin in vivo.
    Persson MG; Agvald P; Gustafsson LE
    Br J Pharmacol; 1994 Mar; 111(3):825-8. PubMed ID: 8019758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
    Schneeweiss A
    Am J Cardiol; 1988 Mar; 61(9):19E-21E. PubMed ID: 3126632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin ointment in acute myocardial infarction.
    Armstrong PW; Mathew MT; Boroomand K; Parker JO
    Am J Cardiol; 1976 Oct; 38(4):474-8. PubMed ID: 823809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
    Korewicki J; Kraska T; Ostrzycki A; Opolski G
    Cor Vasa; 1985; 27(4):251-8. PubMed ID: 3931975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state maternal and fetal plasma concentrations of glyceryl trinitrate (GTN) in the preterm sheep.
    Bustard MA; Farley AE; Bennett BM; Smith GN
    Can J Physiol Pharmacol; 2003 Sep; 81(9):884-9. PubMed ID: 14614525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of the pharmacokinetic-hemodynamic response to nitroglycerin in the dog: a model for studying the effects of chronic treatment.
    Moffat JA; Abdollah H; Watts DG; Armstrong PW
    J Pharmacol Methods; 1984 Mar; 11(1):41-51. PubMed ID: 6425569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
    Korewicki J; Rajecka A; Pogorzelska H; Madeja G
    Kardiol Pol; 1990; 33(6):365-74. PubMed ID: 2128094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.